![Jiangsu Recbio Technology Co., Ltd. logo](/logos/2179.HK.webp)
Jiangsu Recbio Technology Co., Ltd.
HKEX:2179.HK
Overview | Financials
Company Name | Jiangsu Recbio Technology Co., Ltd. |
Symbol | 2179.HK |
Currency | HKD |
Price | 8.8 |
Market Cap | 4,316,931,617 |
Dividend Yield | 0% |
52-week-range | 7.39 - 13 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Yong Liu |
Website | https://www.recbio.cn |
An error occurred while fetching data.
About Jiangsu Recbio Technology Co., Ltd.
Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People's Republic of China. The company is developing vaccines for the treatment of cervical cancer and genital warts, including REC603, a recombinant human papillomavirus (HPV) 9-valent vaccine that is in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD